Journal of Neonatal Biology

Sedation with dexmedetomidine on Klippel Feil syndrome infant patient

20^th International Conference on Neonatology and Perinatology

December 04-06, 2017 | Madrid, Spain

Ahmet Selim Ozkan, Sedat Akbas, Mehmet Ali Erdogan, Ramazan K�±rteke and Mahmut Durmus

Inonu University, Turkey

Scientific Tracks Abstracts: J Neonatal Biol

Abstract:

Introduction: Klippel Feil Syndrome (KFS) is a congenital malformation which has a failure of segmantation of cervical somites in the 8th week of gestation and fusion at least two cervical segments. It is described as the triad of short neck, low posterior hairline and decreased range of neck motions. Especially decreased range of neck motions lead many anesthesiologists to difficulty in airway management. Dexmedetomidine is used for sedation especially without respiratory depression but use in very early age group pediatric patients was not observed in reported cases. In this case; we aimed to present succesfull sedation by dexmedetomidine in infant patient who is 65 days aged, diagnosed KFS, limited neck motions and known difficult airway. Case Report: Infant patient, who is 65 days aged, 4 kg weight, 81 cm height and diagnosed KFS, was scheduled for a neck MRI. On evaluation of patient; short neck, low posterior hairline, thorax deformity and floating finger was found. The mouth opening of patient was normal but the extension of neck was particularly restricted. Systemic examination revealed no other abnormalities. The chest X-ray showed hypoplastic ribs. In medical history of patient; there was intermittent respiratory distress. The patient was taken to the anesthetic preparation room. Standard monitorization (electrocardiography, heart rate, oxygen saturation) were performed and intravenous (IV) line was obtained. After preoxygenation for 5 minutes by facemask, dexmedetomidine infusion was administered by IV route as bolus of 0.5 mcg / kg dose for 10 minutes. Monitorization data and Ramsey Sedation Score of the patient were recorded at intervals of 5 minutes. Ear plugs was inserted into patient for protection of loud sounds in MRI room. After bolus administration, dexmedetomidine infusion was continued for maintenance dose as 0.6 mg/kg/hour. Dexmedetomidine infusion was continued for 20 minutes throughout the procedure. Mean values of monitoring data of the patient were recorded as peripheral oxygen saturation: 98% (range 96-99), heart rate: 138 beats/min (range 130171), respiratory rate: 26/min (range 23-30). During the process, Ramsey Sedation Score was found 4. Dexmedetomidine infusion was terminated at the end of operation and patient follow-up was continued in the postanesthesia care unit. Patient was sent to service after the full awakeness and the patient was discharged on the same day. Conclusion: Because of beneficial effects, we approved the administration of dexmedetomidine to 65 days aged infant and diagnosed KFS patient. Sedation is important in such cases which is considered limitted neck motions and difficult airway. We believe that dexmedetomidine is an agent which may prefer as an alternative agent ensuring respiratory control in anesthesia procedures for sedation.

Biography :

Ahmet Selim Ozkan has completed his PhD form Kartal Medical Hospital and Post-doctoral studies from Inonu UniversÅ?ty School of Medicine. He is working at Inonu University School of Medicine, Anesthesiology and Reanimation Department. He has more papers about anesthesiology and pharmacology study.